chr1-161236108-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005122.5(NR1I3):​c.108-131C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 1,045,210 control chromosomes in the GnomAD database, including 12,997 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1348 hom., cov: 31)
Exomes 𝑓: 0.16 ( 11649 hom. )

Consequence

NR1I3
NM_005122.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.418

Publications

7 publications found
Variant links:
Genes affected
NR1I3 (HGNC:7969): (nuclear receptor subfamily 1 group I member 3) This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020]
NR1I3 Gene-Disease associations (from GenCC):
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.213 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NR1I3NM_005122.5 linkc.108-131C>A intron_variant Intron 2 of 8 ENST00000367983.9 NP_005113.1 Q14994-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NR1I3ENST00000367983.9 linkc.108-131C>A intron_variant Intron 2 of 8 1 NM_005122.5 ENSP00000356962.5 Q14994-2

Frequencies

GnomAD3 genomes
AF:
0.122
AC:
18589
AN:
152108
Hom.:
1344
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0406
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.128
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.223
Gnomad SAS
AF:
0.165
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.157
Gnomad OTH
AF:
0.132
GnomAD4 exome
AF:
0.157
AC:
140248
AN:
892984
Hom.:
11649
Cov.:
12
AF XY:
0.156
AC XY:
70072
AN XY:
448332
show subpopulations
African (AFR)
AF:
0.0382
AC:
789
AN:
20674
American (AMR)
AF:
0.131
AC:
2588
AN:
19744
Ashkenazi Jewish (ASJ)
AF:
0.0990
AC:
1623
AN:
16390
East Asian (EAS)
AF:
0.260
AC:
8769
AN:
33724
South Asian (SAS)
AF:
0.159
AC:
8802
AN:
55414
European-Finnish (FIN)
AF:
0.145
AC:
6121
AN:
42086
Middle Eastern (MID)
AF:
0.119
AC:
457
AN:
3856
European-Non Finnish (NFE)
AF:
0.159
AC:
105108
AN:
660430
Other (OTH)
AF:
0.147
AC:
5991
AN:
40666
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
5756
11512
17267
23023
28779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3302
6604
9906
13208
16510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.122
AC:
18605
AN:
152226
Hom.:
1348
Cov.:
31
AF XY:
0.124
AC XY:
9211
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0405
AC:
1684
AN:
41556
American (AMR)
AF:
0.129
AC:
1964
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
351
AN:
3470
East Asian (EAS)
AF:
0.223
AC:
1159
AN:
5188
South Asian (SAS)
AF:
0.165
AC:
796
AN:
4822
European-Finnish (FIN)
AF:
0.146
AC:
1547
AN:
10596
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.157
AC:
10642
AN:
67994
Other (OTH)
AF:
0.131
AC:
277
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
846
1692
2537
3383
4229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
676
Bravo
AF:
0.118

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.2
DANN
Benign
0.71
PhyloP100
-0.42
PromoterAI
-0.00050
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6686001; hg19: chr1-161205898; COSMIC: COSV63469149; COSMIC: COSV63469149; API